Baker Bros. Advisors Lp - Insider Trading & Ownership

Entity
Company
Location
860 Washington Street, 3 Rd Floor, New York, NY
Summary
The estimated value of insider holdings of Baker Bros. Advisors Lp is at least $7.09B dollars as of December 17, 2024. Baker Bros. Advisors Lp is the Director, 10%+ Owner of INCYTE CORP and owns shares of INCYTE CORP (INCY) stock worth about $1.88B. Baker Bros. Advisors Lp is the Director of BeiGene, Ltd. and owns shares of BeiGene, Ltd. (BGNE) stock worth about $1.66B. Baker Bros. Advisors Lp is the Director of MADRIGAL PHARMACEUTICALS, INC. and owns shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) stock worth about $1.15B. Baker Bros. Advisors Lp is the Director, 10%+ Owner of ACADIA PHARMACEUTICALS INC and owns shares of ACADIA PHARMACEUTICALS INC (ACAD) stock worth about $668M. Baker Bros. Advisors Lp is the Director of Kymera Therapeutics, Inc. and owns shares of Kymera Therapeutics, Inc. (KYMR) stock worth about $648M. Baker Bros. Advisors Lp is the Director, 10%+ Owner of BICYCLE THERAPEUTICS PLC and owns shares of BICYCLE THERAPEUTICS PLC (BCYC) stock worth about $535M. Baker Bros. Advisors Lp is the Director of TScan Therapeutics, Inc. and owns shares of TScan Therapeutics, Inc. (TCRX) stock worth about $308M. Baker Bros. Advisors Lp is the Director of Kiniksa Pharmaceuticals International, plc and owns shares of Kiniksa Pharmaceuticals International, plc (KNSA) stock worth about $68.6M. Baker Bros. Advisors Lp is the Director, 10%+ Owner of Prelude Therapeutics Inc and owns shares of Prelude Therapeutics Inc (PRLD) stock worth about $56.6M. Baker Bros. Advisors Lp is the 10%+ Owner of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $45.8M. Baker Bros. Advisors Lp is the Director, 10%+ Owner of IGM Biosciences, Inc. and owns shares of IGM Biosciences, Inc. (IGMS) stock worth about $43.4M. Baker Bros. Advisors Lp is the Director, 10%+ Owner of DBV Technologies S.A. and owns shares of DBV Technologies S.A. (DBVT) stock worth about $25.4M. Baker Bros. Advisors Lp is the 10%+ Owner of KALA BIO, Inc. and owns shares of KALA BIO, Inc. (KALA) stock worth about $3.82M. Baker Bros. Advisors Lp is the Former 10% Owner of Atreca, Inc. and owns shares of Atreca, Inc. stock worth about $1.2M. Baker Bros. Advisors Lp is the Director, Former 10% Owner of Neurogene Inc. and owns shares of Neurogene Inc. (NGNE) stock worth about $287K. Baker Bros. Advisors Lp is the Director of vTv Therapeutics Inc. and owns shares of vTv Therapeutics Inc. (VTVT) stock worth about $11.6K.
All Insider Reports
All Insider Reports

Ownership of Baker Bros. Advisors Lp

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
INCY INCYTE CORP Director, 10%+ Owner $1.88B Sep 30, 2024
BGNE, BEIGF BeiGene, Ltd. Director $1.66B -$194M -10.5% Dec 9, 2024
MDGL MADRIGAL PHARMACEUTICALS, INC. Director $1.15B +$275M +31.4% Jun 25, 2024
ACAD ACADIA PHARMACEUTICALS INC Director, 10%+ Owner $668M May 29, 2024
KYMR Kymera Therapeutics, Inc. Director $648M +$106M +19.5% Aug 20, 2024
BCYC BICYCLE THERAPEUTICS PLC Director, 10%+ Owner $535M +$21.2M +4.13% Dec 13, 2024
TCRX TScan Therapeutics, Inc. Director $308M +$69M +28.9% Jun 12, 2024
KNSA Kiniksa Pharmaceuticals International, plc Director $68.6M Oct 4, 2024
PRLD Prelude Therapeutics Inc Director, 10%+ Owner $56.6M Jun 14, 2024
TRDA Entrada Therapeutics, Inc. 10%+ Owner $45.8M +$50M Jun 25, 2024
IGMS IGM Biosciences, Inc. Director, 10%+ Owner $43.4M +$3.43M +8.57% Sep 30, 2024
DBVT DBV Technologies S.A. Director, 10%+ Owner $25.4M Jun 13, 2022
KALA KALA BIO, Inc. 10%+ Owner $3.82M Jun 28, 2024
BCEL Atreca, Inc. Former 10% Owner $1.2M Oct 19, 2023
NGNE Neurogene Inc. Director, Former 10% Owner $287K Dec 18, 2023
VTVT vTv Therapeutics Inc. Director $11.6K Jun 25, 2024
SYRE Spyre Therapeutics, Inc. Director Jun 8, 2021
BLCM BELLICUM PHARMACEUTICALS, INC 10%+ Owner Nov 22, 2023
IMCR Immunocore Holdings plc Director May 28, 2024
KOD Kodiak Sciences Inc. Director, 10%+ Owner Jun 28, 2024
SGEN Seagen Inc. Director, Former 10% Owner Dec 14, 2023
TLIS Talis Biomedical Corp Director, 10%+ Owner Jun 9, 2023

Insider Transactions Reported by Baker Bros. Advisors Lp:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.